Evidence map›Paper›PMID 36014371›Full record

ArticleMolecules (Basel, Switzerland)2022

Prediction of Drug-Target Interaction Using Dual-Network Integrated Logistic Matrix Factorization and Knowledge Graph Embedding.

Jiaxin Li, Xixin Yang, Yuanlin Guan, Zhenkuan Pan

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jiaxin LiCollege of Computer Science & Technology, Qingdao University, Qingdao 266071, China.
Xixin YangCollege of Computer Science & Technology, Qingdao University, Qingdao 266071, China.
Yuanlin GuanKey Lab of Industrial Fluid Energy Conservation and Pollution Control, Ministry of Education, Qingdao University of Technology, Qingdao 266520, China.ORCID 0000-0001-5035-9562
Zhenkuan PanCollege of Computer Science & Technology, Qingdao University, Qingdao 266071, China.

Funding

Major Scientific and Technological Innovation Projects of Shandong Prov-ince No.2019JZZY020101Shandong Province Science and Technology SMES Innovation Ability Enhancement Project 2021TSGC1063the project of the Natural Science Foundation of Shandong Province, China (No. ZR2019PEE018) ZR2019PEE018
6 · The paper itself

Abstract

Nowadays, drug-target interactions (DTIs) prediction is a fundamental part of drug repositioning. However, on the one hand, drug-target interactions prediction models usually consider drugs or targets information, which ignore prior knowledge between drugs and targets. On the other hand, models incorporating priori knowledge cannot make interactions prediction for under-studied drugs and targets. Hence, this article proposes a novel dual-network integrated logistic matrix factorization DTIs prediction scheme (Ro-DNILMF) via a knowledge graph embedding approach. This model adds prior knowledge as input data into the prediction model and inherits the advantages of the DNILMF model, which can predict under-studied drug-target interactions. Firstly, a knowledge graph embedding model based on relational rotation (RotatE) is trained to construct the interaction adjacency matrix and integrate prior knowledge. Secondly, a dual-network integrated logistic matrix factorization prediction model (DNILMF) is used to predict new drugs and targets. Finally, several experiments conducted on the public datasets are used to demonstrate that the proposed method outperforms the single base-line model and some mainstream methods on efficiency.

Indexed as

Drug RepositioningPattern Recognition, AutomatedAlgorithmsDrug Delivery SystemsDrug InteractionsLogistic Modelsdrug–target interactions predictiondual-network integrated logistic matrix factorizationknowledge graph embedding

Identifiers

PMID36014371
PMCPMC9412517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.